Evaluation of Serum and Tissue Cathepsin L in Non-segmental Vitiligo Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

March 1, 2025

Study Completion Date

March 1, 2025

Conditions
Vitiligo
Interventions
DIAGNOSTIC_TEST

blood sample and tissue biopsy

Serum level of Cathepsin L: 3 cm of blood will be taken on EDTA tubes from patients and control subjects and will be analyzed by double antibody sandwich enzyme-linked immune-sorbent assay (ELISA) to assess the level of CTSL in blood samples. Tissue expression of Cathepsin L: 5 mm punch biopsies will be taken under local anesthesia from lesions and from the adjacent normal skin of patients (from the lesional and peri-lesional sites). Also, skin biopsy of normal skin will be taken from healthy volunteers. The specimen of skin will be immediately placed in a formalin saline, and then immune-histochemical evaluation will be done to evaluate the CTSL expression in tissue.

All Listed Sponsors
lead

Sohag University

OTHER

NCT06261073 - Evaluation of Serum and Tissue Cathepsin L in Non-segmental Vitiligo Patients | Biotech Hunter | Biotech Hunter